4.6 Article

High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France

Journal

PLOS ONE
Volume 6, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0023514

Keywords

-

Ask authors/readers for more resources

Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observations are of little help to recognise myxovirus infection and implement appropriate prevention measures. The limited use of molecular tools underestimates the role of other common pathogens. Objectives: During the early weeks of the 2009-2010 flu pandemic, a clinical and virological survey was conducted in adult and paediatric patients with ILI referred to two French University hospitals in Paris and Tours. Aims were to investigate the different pathogens involved in ILI and describe the associated symptoms. Methods: H1N1v pandemic influenza diagnosis was performed with real time RT-PCR assay. Other viral aetiologies were investigated by the molecular multiplex assay RespiFinder19 (R). Clinical data were collected prospectively by physicians using a standard questionnaire. Results: From week 35 to 44, endonasal swabs were collected in 413 patients. Overall, 68 samples (16.5%) were positive for H1N1v. In 13 of them, other respiratory pathogens were also detected. Among H1N1v negative samples, 213 (61.9%) were positive for various respiratory agents, 190 in single infections and 23 in mixed infections. The most prevalent viruses in H1N1v negative single infections were rhinovirus (62.6%), followed by parainfluenza viruses (24.2%) and adenovirus (5.3%). 70.6% of H1N1v cases were identified in patients under 40 years and none after 65 years. There was no difference between clinical symptoms observed in patients infected with H1N1v or with other pathogens. Conclusion: Our results highlight the high frequency of non-influenza viruses involved in ILI during the pre-epidemic period of a flu alert and the lack of specific clinical signs associated with influenza infections. Rapid diagnostic screening of a large panel of respiratory pathogens may be critical to define and survey the epidemic situation and to provide critical information for patient management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia

Antoine Chaillon, Chrianna Bharat, Jack Stone, Nicola Jones, Louisa Degenhardt, Sarah Larney, Michael Farrell, Peter Vickerman, Matthew Hickman, Natasha K. Martin, Annick Borquez

Summary: The opioid agonist treatment (OAT) program in New South Wales, Australia has substantially reduced population-level overdose and all-cause mortality over the past 20 years, partially due to high retention rates. Studies showed an impact on reducing overdose and other cause mortality among the cohort by 52.8% and 26.6%, respectively, with estimates of deaths averted and life-years gained per 100 person-years on OAT. Additionally, prison OAT with post-release OAT-linkage accounted for a significant percentage of all deaths averted by the program.

ADDICTION (2022)

Article Respiratory System

The 16S rRNA lung microbiome in mechanically ventilated patients: a methodological study

Melanie Fromentin, Antoine Bridier-Nahmias, Jerome Legoff, Severine Mercier-Delarue, Noemie Ranger, Constance Vuillard, Julien Do Vale, Noemie Zucman, Antonio Alberdi, Jean-Damien Ricard, Damien Roux

Summary: The accuracy of the bacterial lung microbiome composition is highly dependent on the primers used for amplification of the 16s rRNA hypervariable sequence. Comparing two different primer pairs, results show that S-V4 primer pair provides better agreement with conventional microbiology for respiratory samples compared to R-V4 primer pair.

EXPERIMENTAL LUNG RESEARCH (2022)

Article Virology

Phylodynamics of HIV in the Mexico City Metropolitan Region

Santiago Avila-Rios, Claudia Garcia-Morales, Gustavo Reyes-Teran, Andrea Gonzalez-Rodriguez, Margarita Matias-Florentino, Sanjay R. Mehta, Antoine Chaillon

Summary: The phylogeographic investigation of the Mexico City HIV epidemic reveals the complexity of HIV transmission in the region. An active transmission area in the north of the city, with links throughout the region, is identified as a location where targeted interventions could have a more pronounced effect on the entire epidemic.

JOURNAL OF VIROLOGY (2022)

Article Virology

Comparative Dynamics of Delta and Omicron SARS-CoV-2 Variants across and between California and Mexico

Sanjay R. Mehta, Davey M. Smith, Celia Boukadida, Antoine Chaillon

Summary: Evolutionary analysis using viral sequence data can elucidate the epidemiology of transmission of the Delta and Omicron variants of SARS-CoV-2 between California and Mexico. The introduction of these variants coincided with domestic migration events, and the spread of Omicron was consistent with gravity centric patterns within Mexico. Cross-border events accounted for a higher proportion of Omicron movements. Understanding viral transmission patterns can assist governmental responses to viral epidemics.

VIRUSES-BASEL (2022)

Article Microbiology

Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients' Length of Stay in an Emergency Department

Audrey Baron, Olivier Peyrony, Maud Salmona, Nadia Mahjoub, Sami Ellouze, Maud Anastassiou, Constance Delaugerre, Jean-Paul Fontaine, Sylvie Chevret, Jerome LeGoff, Linda Feghoul

Summary: The use of the ID NOW COVID-19 system in an emergency department was found to significantly reduce the length of stay for patients. The implementation of molecular point-of-care testing for SARS-CoV-2 resulted in faster results and decreased overcrowding in the emergency department. This study emphasizes the importance and benefits of COVID-19 molecular point-of-care testing in preventing overcrowding and facilitating patient care and isolation.

MICROBIOLOGY SPECTRUM (2022)

Article Virology

Catching the Wave: Detecting Strain-Specific SARS-CoV-2 Peptides in Clinical Samples Collected during Infection Waves from Diverse Geographical Locations

Subina Mehta, Valdemir M. Carvalho, Andrew T. Rajczewski, Olivier Pible, Bjoern A. Gruening, James E. Johnson, Reid Wagner, Jean Armengaud, Timothy J. Griffin, Pratik D. Jagtap

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a global health crisis, with the emergence of new strains posing challenges in detection. Mass spectrometry (MS)-based methods can help in diagnosing and developing vaccines by detecting and characterizing variant-specific peptide sequences from viral proteins. In this study, a bioinformatics workflow was developed to detect variant-specific peptide sequences from MS data derived from clinical samples. The workflow was shown to be effective in characterizing clinical data from different parts of the world, identifying six SARS-CoV-2 variant-specific peptides suitable for confident detection by MS in commonly collected clinical samples.

VIRUSES-BASEL (2022)

Article Infectious Diseases

Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program

Patricia K. Riggs, Antoine Chaillon, Guochun Jiang, Scott L. Letendre, Yuyang Tang, Jeff Taylor, Andrew Kaytes, Davey M. Smith, Karine Dube, Sara Gianella

Summary: This review summarizes the important scientific, practical, and ethical lessons learned from the Last Gift program in understanding CNS reservoirs, as well as identifies key knowledge gaps in current research.

CURRENT HIV/AIDS REPORTS (2022)

Letter Infectious Diseases

Air detection of monkeypox virus in a dedicated outpatient clinic room for monkeypox infection diagnosis

Guillaume Mellon, Emma Rubenstein, Meghann Antoine, Valentine Marie Ferre, Audrey Gabassi, Jean-Michel Molina, Constance Delaugerre, Jerome LeGoff

JOURNAL OF INFECTION (2023)

Article Immunology

Predictors of COVID-19 vaccine uptake among people who inject drugs

Steffanie A. Strathdee, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson, Davey M. Smith, Antoine Chaillon, Angela R. Bazzi

Summary: This study examined the vaccination uptake among people who inject drugs (PWID) for COVID-19. The results showed that only 37.8% of participants received at least one dose of the vaccine, and 37.5% of vaccinated individuals were previously hesitant about the vaccine. Factors associated with lower vaccination rates included belief in tracking devices in the vaccine and lack of health insurance, while factors associated with higher vaccination rates included receiving influenza vaccines, testing positive for HIV or SARS-CoV-2, older age, knowing more vaccinated people, and recent incarceration.

VACCINE (2023)

Article Public, Environmental & Occupational Health

Cocirculacion y reemplazo de variantes de SARS-CoV-2 en espacios hacinados y poblaciones marginadas en la frontera Mexico-EUA

Antoine Chaillon, Ietza Bojorquez, Jaime Sepulveda, Alicia Yolanda Harvey-Vera, M. Gudelia Rangel, Britt Skaathun, Sanjay R. Mehta, Caroline Ignacio, Magali Porrachia, Davey M. Smith, Steffanie A. Strathdee

Summary: This study investigated the circulating SARS-CoV-2 lineages and recombinant variants among marginalized populations in Tijuana, Mexico. The results showed that the variants were predominantly detected in North and Central America. This highlights the potential for co-circulation of multiple lineages and recombination in high-risk populations in the California-Baja California border region.

SALUD PUBLICA DE MEXICO (2023)

Article Immunology

Circulation of Human Immunodeficiency Virus 1 A6 Variant in the Eastern Border of the European Union-Dynamics of the Virus Transmissions Between Poland and Ukraine

Karol Serwin, Antoine Chaillon, Kaja Scheibe, Anna Urbanska, Bogusz Aksak-Was, Piotr Zabek, Ewa Siwak, Iwona Cielniak, Elzbieta Jablonowska, Kamila Wojcik-Cichy, Pawel Jakubowski, Monika Bociaga-Jasik, Adam Witor, Bartosz Szetela, Milosz Parczewski

Summary: Geospatial A6 transmission networks are expanding in Poland, driven by local viral dispersal and cross-border migration from Ukraine. The recent war in Ukraine may contribute to further introductions, which could increase the burden of HIV in Western European countries.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir Treatment

Aaron F. Carlin, Alex E. Clark, Aaron F. Garretson, William Bray, Magali Porrachia, AsherLev T. Santos, Tariq M. Rana, Antoine Chaillon, Davey M. Smith

Summary: The factors contributing to the rapid emergence of SARS-CoV-2 BA.4 and BA.5 subvariants in populations that experienced recent surges of BA.2 and BA.2.12.1 infections are not understood. Neutralizing antibodies elicited by BA.2 or BA.2.12.1 infections were largely cross-neutralizing but were less effective against BA.5. Treatment with nirmatrelvir/ritonavir (Paxlovid) early after infection was associated with lower levels of neutralizing antibodies.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Immunology

Brief Report: Comparative Analysis of Pre-existing HIV Drug Resistance Mutations in Proviral DNA Using Next-Generation Sequencing and Routine HIV RNA Genotyping

Noah C. Gaitan, Michelle L. D'Antoni, Rima K. Acosta, Sara Gianella, Susan J. Little, Antoine Chaillon

Summary: Deep sequencing can detect transmitted drug resistance mutations that are not detected by routine sequencing in antiretroviral-naive persons with acute/early HIV infection. High-frequency and low-frequency DRM can be found in HIV DNA, and the presence of low-frequency DRM in proviral DNA may have clinical relevance.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2023)

Review Virology

Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs

Mattia Trunfio, Antoine Chaillon, Nadejda Beliakova-Bethell, Robert Deiss, Scott L. Letendre, Patricia K. Riggs, Niamh Higgins, Sara Gianella

Summary: People with HIV are more likely to have opioid use disorder and prescribed opioids for chronic pain. The effects of opioids on the immune system and HIV persistence are not fully understood. Opioids can enhance HIV infectivity and replication, modulate immune cell functioning, reverse viral latency, and affect HIV reservoirs. Further research is needed in this field.

VIRUSES-BASEL (2023)

Article Medicine, Research & Experimental

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy

Yuyang Tang, Antoine Chaillon, Sara Gianella, Lilly M. Wong, Dajiang Li, Theresa L. Simermeyer, Magali Porrachia, Caroline Ignacio, Brendon Woodworth, Daniel Zhong, Jiayi Du, Eduardo de la Parra Polina, Jennifer Kirchherr, Brigitte Allard, Matthew L. Clohosey, Matt Moeser, Amy L. Sondgeroth, Gregory D. Whitehill, Vidisha Singh, Amir Dashti, Davey M. Smith, Joseph J. Eron, Katherine J. Bar, Ann Chahroudi, Sarah B. Joseph, Nancie M. Archin, David M. Margolis, Guochun Jiang

Summary: Reservoirs of human immunodeficiency virus 1 (HIV) may exist in brain microglia, which can cause rebound viremia after antiretroviral therapy cessation, but the presence of replication-competent HIV in these cells has not been proven yet. In this study, brain myeloid cells (BrMCs) isolated from nonhuman primates and HIV-infected individuals were found to contain detectable levels of SIV or HIV DNA, indicating persistent viral infection. These findings suggest that brain microglia serve as a long-term reservoir for replication-competent HIV in the brain.

JOURNAL OF CLINICAL INVESTIGATION (2023)

No Data Available